The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact

The Use of Sodium Glucose Co-transporter-2 Inhibitors in the Treatment of Heart Failure

by Dragana Vlaski, 2024 PharmD Candidate, Timothy H. Vogt, 2024 PharmD Candidate 

Heart failure (HF) is a clinical manifestation showing functional impairment and anatomical changes of the heart resulting in inadequate filling or ejection of blood from the heart. Symptoms arise over time as cardiac output declines, making it difficult for the heart to support the body’s blood and oxygen needs. Congestive HF is a highly prevalent, chronic condition that affects a little more than 6 million patients in the United States. The number of people diagnosed with heart failure is increasing and projected to rise 46 percent by 2030. As this condition can get worse if left untreated, it is imperative that patients remain adherent to medications and make any needed changes in diet, physical activity, and lifestyle to have the best quality of life possible. 


Keywords: Stroke Volume, Heart Failure, Quality of Life, Diabetes Mellitus, Type 2, Antihypertensive Agents, Cardiotoxins, Cardiovascular Diseases, Heart Ventricles, Hypercholesterolemia, Sodium-Glucose Transporter 2 Inhibitors, Risk Factors, Myocardial Infarction, Disease Progression, Myocardial Ischemia, Heart Valve Diseases, Chronic Disease, Genetic Testing, Healthy Lifestyle, Primary Prevention, Exercise, Cardiomyopathies, Myocardium, Hypertension, Counseling, Delivery of Health Care, Lifestyle, Obesity, Sodium, Diet

​Download PDF 

2022 November/December Table of Contents 

The Journal of the Pharmacy Society of Wisconsin


Past Issues

2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

thejournal@pswi.org
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact